Plus Therapeutics下跌5%，为1700万股二次发行提交招股说明书

• Plus Therapeutics (NASDAQ:PSTV) filed a prospectus for the sale of up to 17M shares by Lincoln Park Capital Fund, or the selling stockholder.
• The company will not receive any of the proceeds from the sale, but may separately receive up to $50M from stock sale to Lincoln Park under the purchase agreement.
• According to the purchase agreement, Lincoln Park has agreed to purchase $50M of stock from time to time over the term of the purchase agreement.
• The stock price dropped about 4.5% on Wednesday during pre-market hours of trading.

More on Plus Therapeutics

• Plus Therapeutics, Inc. (PSTV) Q4 2024 Earnings Call Transcript
• Plus Therapeutics receives Nasdaq delinquency notice
• Plus Therapeutics outlines REYOBIQ expansion plans and CNSide launch timeline
• Seeking Alpha’s Quant Rating on Plus Therapeutics
• Historical earnings data for Plus Therapeutics